Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Traws Pharma, Inc.ONTX · Entity 8032 | Director | August 10, 2023 | August 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Traws Pharma, Inc.
Report date August 10, 2023 · Filed August 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.02 · Expires 2033-08-10 | Direct | 66,468 |
Reported balance
After 2023-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-10 · Grant · Acquired 66,468 · Balance 66,468 F1: These options vest 100% on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest 100% on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2023 Filed Aug 14, 2023 21:43 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 66,468 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001415889-23-012228 · form4-08142023_090819.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,468 Underlying: Common Stock · 66,468 shares Expires 2033-08-10 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 20:54 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 66,468 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001415889-22-008910 · form4-08192022_010815.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,468 Underlying: Common Stock · 66,468 shares Expires 2032-08-18 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:11 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007788 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 21:28 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Appreciation Right · Derivative | 125,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001179110-20-008191 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-07-09 F1 · derivative.exercise_date: These stock appreciation rights vest 100% on the first anniversary of the grant date. Read SEC document |
| May 19, 2020 Filed May 21, 2020 21:10 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | PurchaseCommon Stock | 10,000 | $0.36 | $3,626.00 |
DisclosureSEC source: 0001179110-20-006452 · edgar.xml · nonDerivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,001 Read SEC document |
| July 26, 2019 Filed Jul 29, 2019 21:27 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 5,833 | $0.00 Strike: $3.39 | $0.00 |
DisclosureSEC source: 0001179110-19-008871 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833 Underlying: Common Stock · 5,833 shares Expires 2029-07-26 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 21:28 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 87,500 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001179110-18-010011 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-07-26 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 21:00 UTC | Traws Pharma, Inc. ONTX · Entity 8032 | GrantStock Option (right to purchase) · Derivative | 1,500 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001179110-17-008992 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2027-06-12 F1 · derivative.exercise_date: These options vest over one year from the grant date in 12 equal monthly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.